Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8277513rdf:typepubmed:Citationlld:pubmed
pubmed-article:8277513lifeskim:mentionsumls-concept:C0029144lld:lifeskim
pubmed-article:8277513lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8277513lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8277513lifeskim:mentionsumls-concept:C1751432lld:lifeskim
pubmed-article:8277513lifeskim:mentionsumls-concept:C2699488lld:lifeskim
pubmed-article:8277513lifeskim:mentionsumls-concept:C0380600lld:lifeskim
pubmed-article:8277513pubmed:issue26lld:pubmed
pubmed-article:8277513pubmed:dateCreated1994-2-4lld:pubmed
pubmed-article:8277513pubmed:abstractTextAn improved method for synthesis and resolution of (R,S)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin (trans-7-OH-PlPAT,5), a new D3 dopamine receptor ligand, was reported. Both isomers, (R)-(+)- and (S)-(-)-5, were prepared and characterized. HPLC retention times obtained on a chiral column for these isomers were consistent with those observed for [125I]-(R)-(+)- and (S)-(-)-5. Direct radioiodination of an optically resolved tin precursor, (R)-(+)-7, yielded the desired [125I](R)-(+)-5, which is a simpler method for synthesis of this ligand. Binding studies with membrane preparations containing D3 dopamine receptors expressed in Spodoptera frugiperda (Sf9) cells also suggested that the [125I](R)-(+)-5 is the active isomer (Kd = 0.05 nM). The schemes described may provide an efficient way for synthesizing a large quantity of this new D3 dopamine receptor ligand for in vivo behavior studies.lld:pubmed
pubmed-article:8277513pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:languageenglld:pubmed
pubmed-article:8277513pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:citationSubsetIMlld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8277513pubmed:statusMEDLINElld:pubmed
pubmed-article:8277513pubmed:monthDeclld:pubmed
pubmed-article:8277513pubmed:issn0022-2623lld:pubmed
pubmed-article:8277513pubmed:authorpubmed-author:MARSP HPHlld:pubmed
pubmed-article:8277513pubmed:authorpubmed-author:KunsM DMDlld:pubmed
pubmed-article:8277513pubmed:authorpubmed-author:ChumpraditSSlld:pubmed
pubmed-article:8277513pubmed:issnTypePrintlld:pubmed
pubmed-article:8277513pubmed:day24lld:pubmed
pubmed-article:8277513pubmed:volume36lld:pubmed
pubmed-article:8277513pubmed:ownerNLMlld:pubmed
pubmed-article:8277513pubmed:authorsCompleteYlld:pubmed
pubmed-article:8277513pubmed:pagination4308-12lld:pubmed
pubmed-article:8277513pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:meshHeadingpubmed-meshheading:8277513-...lld:pubmed
pubmed-article:8277513pubmed:year1993lld:pubmed
pubmed-article:8277513pubmed:articleTitleSynthesis and optical resolution of (R)- and (S)-trans-7-Hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino]tetralin: a new D3 dopamine receptor ligand.lld:pubmed
pubmed-article:8277513pubmed:affiliationDepartment of Radiology, University of Pennsylvania, Philadelphia 19104.lld:pubmed
pubmed-article:8277513pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8277513pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8277513lld:chembl